The antioxidant potential of the cirrhotic patients were also shown to be significantly disturbed (controls, 2639.5 ± 255.9 μM; chronic hepatitis patients, 2494.6 ± 197.6 μM; CP-A cirrhosis patients, 1976.2 ± 251.6 μM; CP-B cirrhosis patients, 1833.1 ± 261.7 μM; CP-C cirrhosis patients, 1645.6 ± 210.3 μM) (Fig. 3b). This evidence concerns the gene CP and Cirrhosis.